Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant/Adjuvant Gleevec for Operable GIST
NCT00028002Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2002
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by National Cancer Institute. Started Mar 2002; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00028002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028002.